Medicamen Biotech Ltd

Stage 1 · Basing · week 5

Medicamen Biotech Limited, a pharmaceutical company, research, develops, manufactures, markets, sells, and distributes pharmaceutical formulations in India and internationally. More about the company

₹313.3
+0.42% today
₹425 Cr · Micro cap
Market Neutral — FadingHealth Care 45.7% in Stage 2-1.4 pts / 20dPharmaceuticals 53.8%+3.8 pts
Loading price chart…
vs 52W High
-24.7%
₹219.9 lo₹416 hi
24.7% below 52W high — deeper pullback
Stock is basing below old highs. A volume-backed breakout to new highs would be the Stage 2 signal to watch.
Stage Maturity
Week 5
1w13w26w
Week 5 — early base, needs time
How long this stock has been basing. Longer bases can produce stronger breakouts — but don't anticipate, wait for the breakout.
vs 200 DMA
9.2%
200 DMA: ₹286.8 · sloping down
Stock is testing its 200 DMA as part of the base. Reclaiming and holding above it is a key Stage 2 prerequisite.
Rel Volume
0.39x
vs 50-day avg
Volume in Stage 1 basing is typically quiet. A surge in volume on an upside breakout is the signal to watch.
Trend Health
↑
MA20 trending up · +10.5% vs MA50 +11.9%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
1M
+15.9%
3M
+24.7%
6M
+38.5%
YTD
-20.0%
1Y
+3.2%
Sector
Health Care
↓ Peaking
Stage 2%
45.7%
20d Δ
-1.4pp
1M return
-1.8%
3M return
+4.4%
Sector Stage-2 % · last 20 days
Sector has 77 Stage 2 leaders. See Health Care Stage 2 →
Industry
Pharmaceuticals
↑ Building
Stage 2%
53.8%
20d Δ
+3.8pp
1M return
-0.9%
3M return
+3.6%
Industry Stage-2 % · last 20 days
Industry has 61 Stage 2 leaders. See Pharmaceuticals Stage 2 →
Stage Cycle Timeline2023-07-11 → 2026-10-07
S4 32w
S4 28w
S4 31w
2023-07-112026-10-07
S1S2S3S4Setup score (0–10, dashed line at 5)
S4 1w → S1 5w → S2 4w → S3 3w → S4 32w → S1 9w → S4 10w → S1 3w → S2 10w → S3 5w → S2 1w → S3 4w → S4 5w → S1 1w → S4 28w → S1 9w → S2 1w → S1 1w → S4 31w → S1 5w current
Total tracked: 168 weeks across 20 stage runs.
Scan Membership
Breakout Watch
Latest: 2026-01-13
3 appearances in last 60 days. First seen: 2024-10-28.
Stocks that stay in the scan for 13+ weeks are in the highest observed-return cohort — they keep qualifying because the structure remains intact, not by luck. Persistence in the scan is itself a quality signal.
Recent Stage Timeline
2026-10-07S1
Wk 5 · Vol 0.39x
2026-10-06S1
Wk 5 · Vol 0.27x
2026-10-05S1
Wk 4 · Vol 0.31x
2026-10-01S1
Wk 4 · Vol 0.55x
2026-09-30S1
Wk 4 · Vol 0.37x
2026-09-29S1
Wk 4 · Vol 0.45x
2026-09-28S1
Wk 4 · Vol 0.76x
2026-09-25S1
Wk 3 · Vol 0.68x
2026-09-24S1
Wk 3 · Vol 0.31x
2026-09-23S1
Wk 3 · Vol 0.18x
2026-09-22S1
Wk 3 · Vol 0.38x
2026-09-21S1
Wk 3 · Vol 0.46x
Sector Peers — Stage 2All →
KOPRAN
wk 19 · -5.0% from hi
9.0
SMSPHARMA
wk 3 · -3.0% from hi
8.7
KILITCH
wk 2 · -1.7% from hi
8.7
BAFNAPH
wk 17 · 0.0% from hi
8.6
ZIMLAB
wk 21 · 0.0% from hi
8.3
Moving averages & range
50 DMA
₹273.5
200 DMA
₹286.8
52W High
₹416
52W Low
₹219.9
5D Low
₹308
Resistance levels (recent highs)
20d High
₹346.3
60d High
₹346.3
120d High
₹346.3
250d High
₹416
Next resistance
+10.6%
to 20d High
Ask the Market AI about MEDICAMEQAsk →
P/E (TTM)
48.8
Forward —
Earnings Growth (YoY)
-47.4%
Revenue +5.1%
Dividend Yield
0.37%
P/B 1.8
About this companyHealth Care· Pharmaceuticals

Medicamen Biotech Limited, a pharmaceutical company, research, develops, manufactures, markets, sells, and distributes pharmaceutical formulations in India and internationally. The company offers drugs in various forms, including tablet, capsule, syrups, oral solution, and drops. Its products are used in therapeutic areas comprising cancer care, cardiology, CNS, diabetology, anti-infective, anti-malarials, vitamins, antibiotics, and supplements, other generics, and pain management. The company was incorporated in 1993 and is based in New Delhi, India.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-07. Past data patterns are not indicative of future results. This page is a data analytics tool only.